Global Surgical Forceps Market Overview

The Surgical Forceps Market is expected to grow at a significant growth rate, and the analysis period is 2022-2028, considering the base year as 2021.

An instrument for grasping, holding firmly, or exerting traction upon objects, especially for delicate operations (as by surgeons, obstetricians, or dentists). A wide range of medical treatments involve the utilization of forceps, and the healthcare industry has demonstrated an impressive amount of zeal in its efforts to combat the growing incidence of chronic diseases. Additionally, the medical industry has shown evidence of innovation by introducing a variety of cutting-edge pieces of equipment, such as surgical forceps. The utilization of surgical forceps is essential to the operation of a variety of different kinds of equipment and tools. They come in handy when one needs to hold a lot of things at once or when one's fingers are too large to properly grasp smaller items. Basic surgical forceps can be broken down into four categories, denoted by the duties that they perform: sterilizing treatments, cleaning chemicals, secretions, and body fluids. Most of the time, they are made out of carbon steel of high quality. Some of them are fabricated with high-quality stainless-steel alloys, such as chromium and vanadium, to ensure that the edge will not rust and will last for a long time. The steel of lower quality is used to make forceps that are designed for use in different contexts. Plastic is the material of choice for manufacturing the most disposable forceps.

Market Dynamics And Factors For Surgical Forceps Market

Drivers:

• Increasing Availability of High-Quality Forceps

Restraints:

• Strict Government Regulation and Reimbursement Policies

Opportunity:

• Advanced Designs and Safety Features

Regional Analysis Of The Surgical Forceps Market

The market for surgical forceps in North America has grown to become the most lucrative and dominant one worldwide. The high disposable incomes, presence of large enterprises, and well-established healthcare sector in North America are mostly responsible for the market's revenue growth. Other contributing factors include the presence of well-established healthcare services. Additionally, it is anticipated that the growing prevalence of cardiovascular and neurological problems in North America would lead to an increase in the total number of surgical procedures performed there.

Covid-19 Impact Analysis On Surgical Forceps Market

As a result of the outbreak of the coronavirus (COVID-19), the sanitation of surgical equipment is more crucial than it has ever been. In an effort to stop the spread of COVID-19, medical facilities are being inspected to ensure that surgical equipment has been properly sterilized. Because COVID-19 is still rampant in large nations including the United States, India, Russia, and Brazil, medical facilities are under a lot of pressure to prevent the spread of the coronavirus through infected surgical tools. As a consequence of this, businesses that manufacture surgical equipment are beginning to implement safety precautions in order to effectively sterilize and clean the instruments before they are shipped to medical facilities. It is possible for medical facilities that do not have the appropriate equipment on-site for sterilization to contribute to an increased rate of coronavirus transmission among patients. In light of the fact that healthcare systems are already being taxed by an increasing number of COVID-19 patients, it is of the utmost importance for businesses in the surgical equipment market to provide instruments that have been properly sterilized and can be used in direct correlation with surgical procedures.

Top Key Players Covered In Surgical Forceps Market

• MedGyn Products (United States)
• Delacroix Chevalier (Europe)
• Shanghai Medical Instruments (China)
• Medline (United States)
• B. Braun (Germany)
• Sklar (United States)
• Xinhua Surgical (China)
• Hu-Friedy (United States)
• Teleflex Medical (United States)
• J and J Instruments (United States)
• Ted Pella (United States)
• Scanlan International (United States), and Other Major Players

Key Industry Development In The Surgical Forceps Market

In June 2022, Xenco Medical expanded its Ambulatory Surgical Centers surgical device portfolio with the approval and launch of its Multilevel CerviKit by the US Food and Drug Administration. Single-use cervical spine technology includes a full suite of implants and single-use instruments for 2, 3, and 4-level anterior cervical spine procedures.

In June 2022, Ethicon, a Johnson & Johnson MedTech division, launched the ECHELON 3000 Stapler in the United States. It is a digitally enabled device that allows surgeons to address the unique needs of their patients with simple, one-handed powered articulation.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Surgical Forceps Market by Product Type
 5.1 Surgical Forceps Market Overview Snapshot and Growth Engine
 5.2 Surgical Forceps Market Overview
 5.3 Hemostatic
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Hemostatic: Geographic Segmentation
 5.4 Thumb Forceps
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Thumb Forceps: Geographic Segmentation
 5.5 Fine Artery Forceps
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Fine Artery Forceps: Geographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation

Chapter 6: Surgical Forceps Market by End-User
 6.1 Surgical Forceps Market Overview Snapshot and Growth Engine
 6.2 Surgical Forceps Market Overview
 6.3 Gynecology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Gynecology: Geographic Segmentation
 6.4 General surgery
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 General surgery: Geographic Segmentation
 6.5 Neurosurgery
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Neurosurgery: Geographic Segmentation
 6.6 Plastic surgery
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Plastic surgery: Geographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Surgical Forceps Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Surgical Forceps Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Surgical Forceps Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 MEDGYN PRODUCTS (UNITED STATES)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 DELACROIX CHEVALIER (EUROPE)
 7.4 SHANGHAI MEDICAL INSTRUMENTS (CHINA)
 7.5 MEDLINE (UNITED STATES)
 7.6 B. BRAUN (GERMANY)
 7.7 SKLAR (UNITED STATES)
 7.8 XINHUA SURGICAL (CHINA)
 7.9 HU-FRIEDY (UNITED STATES)
 7.10 TELEFLEX MEDICAL (UNITED STATES)
 7.11 J AND J INSTRUMENTS (UNITED STATES)
 7.12 TED PELLA (UNITED STATES)
 7.13 SCANLAN INTERNATIONAL (UNITED STATES)
 7.14 OTHER MAJOR PLAYERS

Chapter 8: Global Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Product Type
  8.2.1 Hemostatic
  8.2.2 Thumb Forceps
  8.2.3 Fine Artery Forceps
  8.2.4 Others
 8.3 Historic and Forecasted Market Size By End-User
  8.3.1 Gynecology
  8.3.2 General surgery
  8.3.3 Neurosurgery
  8.3.4 Plastic surgery
  8.3.5 Others

Chapter 9: North America Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Product Type
  9.4.1 Hemostatic
  9.4.2 Thumb Forceps
  9.4.3 Fine Artery Forceps
  9.4.4 Others
 9.5 Historic and Forecasted Market Size By End-User
  9.5.1 Gynecology
  9.5.2 General surgery
  9.5.3 Neurosurgery
  9.5.4 Plastic surgery
  9.5.5 Others
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product Type
  10.4.1 Hemostatic
  10.4.2 Thumb Forceps
  10.4.3 Fine Artery Forceps
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Gynecology
  10.5.2 General surgery
  10.5.3 Neurosurgery
  10.5.4 Plastic surgery
  10.5.5 Others
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Hemostatic
  11.4.2 Thumb Forceps
  11.4.3 Fine Artery Forceps
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By End-User
  11.5.1 Gynecology
  11.5.2 General surgery
  11.5.3 Neurosurgery
  11.5.4 Plastic surgery
  11.5.5 Others
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Hemostatic
  12.4.2 Thumb Forceps
  12.4.3 Fine Artery Forceps
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By End-User
  12.5.1 Gynecology
  12.5.2 General surgery
  12.5.3 Neurosurgery
  12.5.4 Plastic surgery
  12.5.5 Others
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Surgical Forceps Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Hemostatic
  13.4.2 Thumb Forceps
  13.4.3 Fine Artery Forceps
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By End-User
  13.5.1 Gynecology
  13.5.2 General surgery
  13.5.3 Neurosurgery
  13.5.4 Plastic surgery
  13.5.5 Others
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SURGICAL FORCEPS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SURGICAL FORCEPS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SURGICAL FORCEPS MARKET COMPETITIVE RIVALRY
TABLE 005. SURGICAL FORCEPS MARKET THREAT OF NEW ENTRANTS
TABLE 006. SURGICAL FORCEPS MARKET THREAT OF SUBSTITUTES
TABLE 007. SURGICAL FORCEPS MARKET BY PRODUCT TYPE
TABLE 008. HEMOSTATIC MARKET OVERVIEW (2016-2028)
TABLE 009. THUMB FORCEPS MARKET OVERVIEW (2016-2028)
TABLE 010. FINE ARTERY FORCEPS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. SURGICAL FORCEPS MARKET BY END-USER
TABLE 013. GYNECOLOGY MARKET OVERVIEW (2016-2028)
TABLE 014. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
TABLE 015. NEUROSURGERY MARKET OVERVIEW (2016-2028)
TABLE 016. PLASTIC SURGERY MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. NORTH AMERICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 019. NORTH AMERICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 020. N SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 021. EUROPE SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 022. EUROPE SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 023. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 024. ASIA PACIFIC SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 025. ASIA PACIFIC SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 026. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 029. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 030. SOUTH AMERICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 031. SOUTH AMERICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 032. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 033. MEDGYN PRODUCTS (UNITED STATES): SNAPSHOT
TABLE 034. MEDGYN PRODUCTS (UNITED STATES): BUSINESS PERFORMANCE
TABLE 035. MEDGYN PRODUCTS (UNITED STATES): PRODUCT PORTFOLIO
TABLE 036. MEDGYN PRODUCTS (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. DELACROIX CHEVALIER (EUROPE): SNAPSHOT
TABLE 037. DELACROIX CHEVALIER (EUROPE): BUSINESS PERFORMANCE
TABLE 038. DELACROIX CHEVALIER (EUROPE): PRODUCT PORTFOLIO
TABLE 039. DELACROIX CHEVALIER (EUROPE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. SHANGHAI MEDICAL INSTRUMENTS (CHINA): SNAPSHOT
TABLE 040. SHANGHAI MEDICAL INSTRUMENTS (CHINA): BUSINESS PERFORMANCE
TABLE 041. SHANGHAI MEDICAL INSTRUMENTS (CHINA): PRODUCT PORTFOLIO
TABLE 042. SHANGHAI MEDICAL INSTRUMENTS (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. MEDLINE (UNITED STATES): SNAPSHOT
TABLE 043. MEDLINE (UNITED STATES): BUSINESS PERFORMANCE
TABLE 044. MEDLINE (UNITED STATES): PRODUCT PORTFOLIO
TABLE 045. MEDLINE (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. B. BRAUN (GERMANY): SNAPSHOT
TABLE 046. B. BRAUN (GERMANY): BUSINESS PERFORMANCE
TABLE 047. B. BRAUN (GERMANY): PRODUCT PORTFOLIO
TABLE 048. B. BRAUN (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. SKLAR (UNITED STATES): SNAPSHOT
TABLE 049. SKLAR (UNITED STATES): BUSINESS PERFORMANCE
TABLE 050. SKLAR (UNITED STATES): PRODUCT PORTFOLIO
TABLE 051. SKLAR (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. XINHUA SURGICAL (CHINA): SNAPSHOT
TABLE 052. XINHUA SURGICAL (CHINA): BUSINESS PERFORMANCE
TABLE 053. XINHUA SURGICAL (CHINA): PRODUCT PORTFOLIO
TABLE 054. XINHUA SURGICAL (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. HU-FRIEDY (UNITED STATES): SNAPSHOT
TABLE 055. HU-FRIEDY (UNITED STATES): BUSINESS PERFORMANCE
TABLE 056. HU-FRIEDY (UNITED STATES): PRODUCT PORTFOLIO
TABLE 057. HU-FRIEDY (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. TELEFLEX MEDICAL (UNITED STATES): SNAPSHOT
TABLE 058. TELEFLEX MEDICAL (UNITED STATES): BUSINESS PERFORMANCE
TABLE 059. TELEFLEX MEDICAL (UNITED STATES): PRODUCT PORTFOLIO
TABLE 060. TELEFLEX MEDICAL (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. J AND J INSTRUMENTS (UNITED STATES): SNAPSHOT
TABLE 061. J AND J INSTRUMENTS (UNITED STATES): BUSINESS PERFORMANCE
TABLE 062. J AND J INSTRUMENTS (UNITED STATES): PRODUCT PORTFOLIO
TABLE 063. J AND J INSTRUMENTS (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. TED PELLA (UNITED STATES): SNAPSHOT
TABLE 064. TED PELLA (UNITED STATES): BUSINESS PERFORMANCE
TABLE 065. TED PELLA (UNITED STATES): PRODUCT PORTFOLIO
TABLE 066. TED PELLA (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. SCANLAN INTERNATIONAL (UNITED STATES): SNAPSHOT
TABLE 067. SCANLAN INTERNATIONAL (UNITED STATES): BUSINESS PERFORMANCE
TABLE 068. SCANLAN INTERNATIONAL (UNITED STATES): PRODUCT PORTFOLIO
TABLE 069. SCANLAN INTERNATIONAL (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 070. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 071. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 072. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SURGICAL FORCEPS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SURGICAL FORCEPS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. HEMOSTATIC MARKET OVERVIEW (2016-2028)
FIGURE 013. THUMB FORCEPS MARKET OVERVIEW (2016-2028)
FIGURE 014. FINE ARTERY FORCEPS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. SURGICAL FORCEPS MARKET OVERVIEW BY END-USER
FIGURE 017. GYNECOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 018. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 019. NEUROSURGERY MARKET OVERVIEW (2016-2028)
FIGURE 020. PLASTIC SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. NORTH AMERICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. EUROPE SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. ASIA PACIFIC SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. SOUTH AMERICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)